XML 131 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Reinsurance
12 Months Ended
Dec. 31, 2019
Reinsurance Disclosures [Abstract]  
Reinsurance
Reinsurance
(a) Reinsurance Recoverable on Paid and Unpaid Losses
The Company uses retrocessional agreements to reduce its exposure to risk of loss on reinsurance assumed. These agreements provide for recovery from retrocessionaires of a portion of losses and loss expenses. The Company remains liable to its cedants to the extent that the retrocessionaires do not meet their obligations under these agreements, and therefore the Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk on an ongoing basis. The Company actively manages its reinsurance exposures by generally selecting retrocessionaires having a credit rating of A- or higher. In certain cases where an otherwise suitable retrocessionaire has a credit rating lower than A-, the Company generally requires the posting of collateral, including escrow funds and letters of credit, as a condition to its entering into a retrocession agreement. The Company regularly reviews its reinsurance recoverable balances to estimate an allowance for uncollectible amounts based on quantitative and qualitative factors. There was no allowance for uncollectible reinsurance recoverable at December 31, 2019 and 2018 deemed necessary based on the quantitative and qualitative analysis as collectability was determined to be reasonably assured and given that any recoverables related to reinsurers with ratings below A- or unrated are collateralized.
(b) Ceded Reinsurance
Net premiums written, net premiums earned and losses and loss expenses are reported net of reinsurance in the Company’s Consolidated Statements of Operations. Assumed, ceded and net amounts for the years ended December 31, 2019, 2018 and 2017 were as follows (in thousands of U.S. dollars): 
 
 
Premiums
Written
 
Premiums
Earned
 
Losses and Loss
Expenses
2019
 
 
 
Non-life (1)
 
$
5,792,542

 
$
5,433,357

 
$
3,879,242

Life and Health
 
1,492,778

 
1,489,721

 
1,277,684

Assumed
 
$
7,285,320

 
$
6,923,078

 
$
5,156,926

 
 
 
 
 
 
 
Non-life (1)
 
$
353,735

 
$
375,301

 
$
219,102

Life and Health
 
22,527

 
22,559

 
14,668

Ceded
 
$
376,262

 
$
397,860

 
$
233,770

 
 
 
 
 
 
 
Non-life (1)
 
$
5,438,807

 
$
5,058,056

 
$
3,660,140

Life and Health
 
1,470,251

 
1,467,162

 
1,263,016

Net
 
$
6,909,058

 
$
6,525,218

 
$
4,923,156


 
 
Premiums
Written
 
Premiums
Earned
 
Losses and Loss
Expenses
2018
 
 
 
Non-life
 
$
5,064,780

 
$
4,751,958

 
$
3,566,201

Life and Health
 
1,235,149

 
1,235,973

 
1,035,363

Assumed
 
$
6,299,929

 
$
5,987,931

 
$
4,601,564

 
 
 
 
 
 
 
Non-life
 
$
472,498

 
$
450,096

 
$
397,554

Life and Health
 
24,067

 
24,025

 
10,755

Ceded
 
$
496,565

 
$
474,121

 
$
408,309

 
 
 
 
 
 
 
Non-life
 
$
4,592,282

 
$
4,301,862

 
$
3,168,647

Life and Health
 
1,211,082

 
1,211,948

 
1,024,608

Net
 
$
5,803,364

 
$
5,513,810

 
$
4,193,255

 
 
Premiums
Written
 
Premiums
Earned
 
Losses and Loss
Expenses
2017
 
 
 
Non-life
 
$
4,604,938

 
$
4,483,662

 
$
3,644,844

Life and Health
 
982,956

 
987,884

 
813,446

Assumed
 
$
5,587,894

 
$
5,471,546

 
$
4,458,290

 
 
 
 
 
 
 
Non-life
 
$
450,129

 
$
428,471

 
$
639,277

Life and Health
 
17,839

 
18,094

 
(21,969
)
Ceded
 
$
467,968

 
$
446,565

 
$
617,308

 
 
 
 
 
 
 
Non-life
 
$
4,154,809

 
$
4,055,191

 
$
3,005,567

Life and Health
 
965,117

 
969,790

 
835,415

Net
 
$
5,119,926

 
$
5,024,981

 
$
3,840,982

 
(1)
Non-life Losses and loss expenses include amounts allocated to Corporate and Other as disclosed in Note 18.